METIS Innovative is a Miami Beach-based venture capital firm founded by practicing neurosurgeons and focused exclusively on early-stage neurodevice technologies. It is one of the most specialized firms in this list, with a mandate centered on clinically meaningful neurological devices. Its identity is strongly shaped by physician-led investment judgment and direct clinical experience.

The firm focuses on neurostimulation, neuromodulation, pain devices, and related technologies for conditions such as Parkinson’s disease, depression, and chronic pain. Its clinical founding team gives it differentiated diligence capabilities and a clear view of unmet need from the physician side. This makes METIS particularly relevant to founders building devices with strong neurology or neurosurgery use cases.

METIS is focused on the United States. For neurotech founders, it is a high-priority specialist investor if the company is device-led and clinically oriented. It is especially well suited to neurostimulation, implantable systems, and technologies where physician credibility and clinical workflow insight matter early.